Contract facts
NONENo full NAICS 511210 intel page yet. Browse NAICS intelligence
LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR. is a federal NONE award for W4pz Usa Med Rsch Acquis Act held by Lovelace Biomedical Research Institute. Estimated value $1.3M ($698K obligated). Current period of performance ends Sep 19, 2026 (potential Sep 22, 2027). Last award drew 1 bidder. Place of performance: SILVER SPRING MD. Related solicitation W81XWH22Q0994.
LICENSE AND MAINTENANCE SUPPORT, ON-SITE SUPPORT SERVICES FOR VSP WRAIR.
Recompete timing
PublicCurrent PoP ends Sep 19, 2026 (30 days remaining). Agencies typically plan 12–18 months ahead — at 1.0 months out, that window is already open. The buying decision is likely already in motion.
Incumbent footprint
Public recordLovelace Biomedical Research Institute — $30.2M obligated across 54 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).
Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →
Frequently asked questions
What is contract W81XWH22P0157?
W81XWH22P0157 (License and maintenance support on-site support) is a W4pz Usa Med Rsch Acquis Act award with a potential value of $1.3M, currently held by Lovelace Biomedical Research Institute. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.
What is W81XWH-22-P-0157?
W81XWH-22-P-0157 is the dashed form of PIID W81XWH22P0157 (License and maintenance support on-site support), held by Lovelace Biomedical Research Institute. Same award — SCOUT canonicalizes compact, dashed, and parent-child identifiers to one brief.
Which office awarded W81XWH22P0157?
W4pz Usa Med Rsch Acquis Act awarded W81XWH22P0157 to Lovelace Biomedical Research Institute (potential $1.3M).
Who is the incumbent on W81XWH22P0157?
Lovelace Biomedical Research Institute is the incumbent with $30.2M across 54 related awards in SCOUT’s public footprint. The current period of performance ends Sep 19, 2026.
When does Lovelace Biomedical Research Institute’s W81XWH22P0157 come up for recompete?
SCOUT tracks a period-of-performance end of Sep 19, 2026. Actual solicitation timing can shift with extensions, bridges, or consolidations.
Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.